Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 10, 2022
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
Norihiro Watanabe, Feiyan Mo, Rong Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine
Yee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
ACS Nano
|
March 21, 2024
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk
Chengyi Li, Ryan Clauson, Luke F Bugada, et al.
Blood
|
June 3, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma
Susan Bal, Myo Htut, Omar Nadeem, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 10, 2022
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
Norihiro Watanabe, Feiyan Mo, Rong Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine
Yee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
ACS Nano
|
March 21, 2024
Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk
Chengyi Li, Ryan Clauson, Luke F Bugada, et al.
Blood
|
June 3, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma
Susan Bal, Myo Htut, Omar Nadeem, et al.
Page
of 7